H. Res. 172 (119th)Bill Overview

Raising awareness for the sarcoma cancer chordoma.

Simple ResolutionHealth|Health
Cosponsors
Support
Democratic
Introduced
Feb 27, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This House resolution expresses support for raising awareness of chordoma, a rare bone cancer of the skull and spine. It calls for increased funding and support for early and accurate diagnosis, development of new treatments and diagnostics, fewer barriers between research and therapies, and patient-centric drug discovery and development.

Why people may split

Scope of federal spending: liberals favor funding; conservatives prefer private/state solutions

Watch point

Simple, non-binding, sympathetic health resolution is typically easy to pass if scheduled.

This House resolution expresses support for raising awareness of chordoma, a rare bone cancer of the skull and spine.

It calls for increased funding and support for early and accurate diagnosis, development of new treatments and diagnostics, fewer barriers between research and therapies, and patient-centric drug discovery and development.

The resolution does not appropriate funds or create new programs; it states the sense of the House.

Passage2/100

As a non-binding House resolution it can pass the House but does not create law; conversion into statute would require additional substantive legislation.

CredibilityPartial

How solid the drafting looks.

Contention12/100

Scope of federal spending: liberals favor funding; conservatives prefer private/state solutions

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitMay raise public and policymaker awareness, potentially catalyzing research interest and fundraising.
  • Potential benefitCould encourage agencies and Congress to prioritize chordoma research funding if follow‑up legislation is introduced.
  • Potential benefitIncreased focus might accelerate development of diagnostics and clinical trials, expanding treatment options for patien…
Likely burdened
  • Potential burdenNonbinding language does not appropriate funds or change law, so immediate practical effects are limited.
  • Federal agenciesMay create expectations of increased federal support without specifying funding sources or implementation mechanisms.
  • Potential burdenTargeted advocacy could divert limited research attention or funding from other diseases with comparable burdens.
03 · Why people split

Why the argument around this bill splits.

Scope of federal spending: liberals favor funding; conservatives prefer private/state solutions
Progressive95%

Likely strongly supportive: views the resolution as a needed statement to mobilize research funding and patient-centered care.

Sees it as aligned with priorities to fund rare-disease research and reduce disparities in access to care.

Leans supportive
Centrist90%

Generally supportive as a nonbinding, bipartisan awareness measure.

Appreciates patient-focused goals but wants clarity on costs, measurable outcomes, and avoiding open-ended federal commitments without oversight.

Leans supportive
Conservative80%

Likely supportive in principle because it advocates for patients and research, but cautious about calls for increased funding.

Concerned about federal spending and regulatory burdens if recommendations lead to programs.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood2/100

As a non-binding House resolution it can pass the House but does not create law; conversion into statute would require additional substantive legislation.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether committee will schedule consideration
  • Number and stature of co-sponsors
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Scope of federal spending: liberals favor funding; conservatives prefer private/state solutions

As a non-binding House resolution it can pass the House but does not create law; conversion into statute would require additional substanti…

Unlocked analysis

Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Raising awareness for the sarcoma cancer chordoma..

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis